Category: Sleep Treatments

Sleep Treatments

Treating Narcolepsy Around the Clock

New data suggest that targeting the underlying orexin deficiency can improve a broad spectrum of narcolepsy type 1 symptoms, from daytime cognition to nighttime sleep architecture.

Sleep Treatments

The Push Precision OSA Care Needed

For years, individualized obstructive sleep apnea care has been more aspiration than routine practice. Pharmacologic therapies may help change that.

Sleep Treatments

Surprising Duration of Self-Maintained Positional Therapy Benefits Offers New OSA Strategy

Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.

CPAP & PAP Devices

How to Afford CPAP + GLP-1 Polytherapy

What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?

Insomnia Devices

Nexalin Acquires Digital Health Platform Ahead of FDA Pivotal Trial for Insomnia Treatment

The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.

Therapy Devices

Nyxoah Initiates Search for US-Based CEO to Accelerate Genio Launch

The medical technology company is transitioning leadership to focus on its next phase of growth and commercial traction for its obstructive sleep apnea therapy in the US market.

Pharmaceuticals

Health Canada Approves Zepbound for OSA in Adults With Obesity

Tirzepatide injection becomes the first medication authorized in Canada for moderate to severe OSA, demonstrating significant reductions in breathing disruptions in clinical trials.

Surgeries & Procedures

Which Costs Less: GLP-1s or Bariatric Surgery?

A retrospective study explores how surgical and pharmacologic weight-loss strategies stack up in cost, effectiveness, and health outcomes.

Behavioral Sleep Medicine

New DARC-NESS Model Explains Why Nightmares Persist in Children

A mastery-based cognitive-behavioral model centers on "nightmare efficacy" to help clinicians create personalized treatment plans for youth.